LPH-5 + Placebo
Phase 1Recruiting 1 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Safety Issues
Conditions
Safety Issues, Tolerance
Trial Timeline
Apr 30, 2025 → Dec 31, 2025
NCT ID
NCT06722820About LPH-5 + Placebo
LPH-5 + Placebo is a phase 1 stage product being developed by Biotrial for Safety Issues. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06722820. Target conditions include Safety Issues, Tolerance.
What happened to similar drugs?
3 of 4 similar drugs in Safety Issues were approved
Approved (3) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
6
Activity
15
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06722820 | Phase 1 | Recruiting |
Competing Products
20 competing products in Safety Issues